A theme covering the advancement of overseas clinical development of drug candidates through a business and capital alliance with Medipal and the U.S. joint venture JCR USA, Inc. It concerns Medipal's acquisition of shares in connection with the alliance and the establishment of a U.S. development structure using the joint venture.